Preview

Meditsinskiy sovet = Medical Council

Advanced search

Microbic eczema – trigger points of influence

https://doi.org/10.21518/ms2022-031

Abstract

The relevance of microbic eczema is caused by prevalence of a disease, a long chronic current, frequent, is long the proceeding recurrence, insufficiently studied pathogeny and difficulties of the choice of effective treatment. Microbic eczema – the chronic recurrent dermatosis which is characterized by evolutionary polymorphism of elements of rash, wet an itch and a peculiar allergic reaction of the sensibilized skin to decomposition products of microorganisms and their toxins arising against the background of it is long the existing piogenic center at disturbance of the major regulatory systems of an organism. At patients with microbic eczema disbioz skin it is shown by reduction of a share of S. epidermidis, Bifidobacterium spp., Lactobaccilus spp. and significant increase in opportunistic and pathogenic flora, associations of mushrooms quite often meet representatives of obligate flora. Allergenic action of S. aureus and fungal microflora, in particular, of C. Albicans at microbic eczema considerably amplify in the conditions of a mikstinfektion. In recent years microbic eczema tends to a heavy current with a frequent long recurrence, considerable distribution of process on skin and is characterized by resistance to the standard methods of treatment. Elimination of action of microbic, mycotic dissimination and normalization of a biocenosis of skin at microbic eczema are the key principle of treatment of patients interfering recuring of chronic eczema. The article focuses on microbial eczema, as the most difficult type of eczema in therapy, presents our own clinical observations of the course of microbial eczema of various localization and severity, and also shows the effectiveness of the Russian-made topical drug Akriderm GK, containing a micronized form of betamethasone dipropionate, gentamicin sulfate and clotrimazole in the complex therapy of patients with microbial eczema.

About the Authors

J. S. Kovaleva
Altay State Medical University
Russian Federation

Julia S. Kovaleva, Dr. Sci. (Med.), Head of the Department of  Dermatovenereology, Cosmetology and Immunology

40, Lenin Ave., Barnaul, Altai Region, 656038, Russia 



N. G. Komkina
Altay State Medical University
Russian Federation

Natalia G. Komkina, Cand. Sci. (Med.), Associate Professor of the Department of Dermatovenereology, Cosmetology and Immunology

40, Lenin Ave., Barnaul, Altai Region, 656038, Russia 



References

1. Rodionov A.N. Dermatovenerology. A complete guide for doctors. Saint Petersburg: Nauka i tekhnika; 2012. 1200 p. (In Russ.) Available at: https://rusneb.ru/catalog/000200_000018_RU_NLR_bibl_1915814.

2. Abdrakhimova N.A., Mustafina G.R., Khismatullina Z.R., Zakharchenko V.D. Immunological concept of microbial eczema davalopment. Bashkortostan Medical Journal. 2014:9(1):109–118. (In Russ.) Available at: https://www.elibrary.ru/download/elibrary_21584337_45002114.pdf.

3. Orkin V.F., Olekhnovich N.M. Microbic eczema: clinic, pathogeny, treatment. Saratov: Northern State Medical University; 2002. 102 p. (In Russ.) Available at: https://rusneb.ru/catalog/000200_000018_RU_NLR_bibl_441086.

4. Potekayev N.N. Eczema: historical aspects and current considerations. Klinicheskaya Dermatologiya i Venerologiya. 2006;(4):102–107. (In Russ.) Available at: https://www.elibrary.ru/item.asp?id=9436163.

5. Sokolova T.V., Malyarchuk A.P. Clinical thinking – a basis of the choice of rational tactics of maintaining patients with microbic eczema. Consilium Medicum. Dermatology. 2011;(2):6–13. (In Russ.) Available at: https://omnidoctor.ru/library/izdaniya-dlya-vrachey/consilium-medicum/cm2011/derma2011_pril%20/derma2011_2_pril/klinicheskoe-myshlenieosnova-vybora-ratsionalnoy-taktiki-vedeniya-bolnykh-mikrobnoy-ekzemoy.

6. Charles J., Pan Y., Miller G. Eczema. Aust Fam Physician. 2011;40(7):467. Available at: https://pubmed.ncbi.nlm.nih.gov/21743849/.

7. Shibayeva E.V., Pyshkina E.I. External therapy of the infected dermatosis: adequate approach to the drug choice. Effective Pharmacotherapy. 2013;(8):10–14. (In Russ.) Available at: https://umedp.ru/articles/naruzhnaya_terapiya_infitsirovannykh_dermatozov_adekvatnyy_podkhod_k_vyboru_preparata.html?sphrase_id=98458.

8. Sokolova T.V., Malyarchuk A.P., Safonova L.A. The strategy of selecting topical therapy for microbial eczema. Klinicheskaya Dermatologiya i Venerologiya. 2017;16(3):46–63. (In Russ.) https://doi.org/10.17116/klinderma201716346-63.

9. Skripkin Yu.K., Butov Yu.S. (eds.). A clinical dermatovenereology. Moscow: GEOTAR-Media; 2009. Vol. 2, 921 p. (In Russ.) Available at: https://search.rsl.ru/ru/record/01004266249.

10. Karaulov A.V., Bykov S.A., Bykov A.S. Immunology, microbiology and immunopathology of the skin. Moscow: BINOM; 2012. 328 p. (In Russ.) Available at: https://search.rsl.ru/ru/record/01005426038.

11. Kubanov A.A., Khardikova S.A., Zaslavskiy D.V., Novikov YU.A., Radul E.V., Pravdina O.V. et al. Federal clinical recommendations about maintaining patients with eczema of RODVK. Moscow; 2021. (In Russ.) Available at: https://www.rodv.ru/upload/iblock/698/69814889b9519ed73c8ba7c-0c7bc4b35.pdf.

12. Yusupovа L.A., Yunusovа E.I., Garaeva Z.S., Mavlyutova G.I., Bildyuk E.V., Shakirova A.N. The modern features of clinical picture, diagnostics and therapy of patients with eczema. Lechaschi Vrach. 2018;(6):85. (In Russ.) Available at: https://journal.lvrach.ru/jour/article/view/536.

13. Adaskevich V.P., Kozin V.M. Skin and venereal diseases. Moscow; 2007. 672 p. (In Russ.) Available at: https://djvu.online/file/Gnowda58cfZaI.

14. Soldatenko N.A., Sherengovskaya Y.V., Prokhorov D.V., Gorlova N.A. Microbial eczema –inflammatory skin disease. Tavricheskiy MedikoBiologicheskiy Vestnik. 2020;23(3):117–124. (In Russ.) Available at: https://ma.cfuv.ru/site/page/show/docid/260743.

15. Bateman T. Practical description of skin diseases, published by doct. Batman, according to the Villan system. Saint Petersburg; 1829. 441 p. (In Russ.) Available at: https://search.rsl.ru/ru/record/01003558103.

16. Gladko V.V., Sokolova T.V., Flaks G.A., Malyarchuk A.P., Safonova L.A. Microbic eczema as an infectious and dependent dermatosis in practice of the dermatovenereologist. Moscow: Moscow State University of Food Production; 2017. 60 p. (In Russ.) Available at: https://www.elibrary.ru/item.asp?id=38562652.

17. Poroshina L.A. Peculiarities of clinical manifestation of infected eczema and approaches to choosing antibiotic therapia. Problems of Health and Ecology. 2015;3(45):38–41. (In Russ.) Available at: https://cyberleninka.ru/article/n/osobennosti-klinicheskih-proyavleniy-infektsionnoy-ekzemypodhody-k-vyboru-antibiotikoterapii.

18. Skripkin Yu.K., Butov Yu.S., Ivanov O.L. (eds.). Dermatovenereology: national guideline. Moscow: GEOTAR-Media; 2011. 1024 p. (In Russ.) Available at: https://obuchalka.org/20200919125103/dermatovenerologiyanacionalnoe-rukovodstvo-skripkin-u-k-butov-u-s-ivanov-o-l-2011.html.

19. Danilova A.A. Ekzema. Consilium Medicum. 1999;1(4):165–168. (In Russ.) Available at: https://consilium.orscience.ru/2075-1753/article/view/91220.

20. Tlish M.M., Popandopulo E.K. Etiopatogeneticheskiye aspects of development of microbic eczema (overview). Saratov Journal of Medical Scientific Research. 2018;14(4):651–656. (In Russ.) Available at: https://ssmj.ru/2018/4/651.

21. Molin S., Vollmer S., Weiss E.H., Weisenseel P., Prinz J.C. Deletion of the late cornified envelope genes LCE3B and LCE3C may promote chronic hand eczema with allergic contact dermatitis. J Investig Allergol Clin Immunol. 2011;21(6):472–479. Режим доступа: https://www.jiaci.org/issues/vol21issue6/vol21issue06-6.htm.

22. Brown S.J., McLean W.H. Eczema genetics: current state of knowledge and future goals. J Invest Dermatol. 2009;129(3):543–552. https://doi.org/10.1038/jid.2008.413.

23. Treadwell P.A. Eczema and infection. Pediatr Infect Dis J. 2008;27(6):551–552. https://doi.org/10.1097/INF.0b013e31817a73ac.

24. Bakulev A.L., Kravchenya S.S., Murashkin N.N., Igonina I.A., Yepifanova A.Yu., Slesarenko N.A. Microbic eczema: new opportunities of the combined topical therapy. Vestnik Dermatologii i Venerologii. 2011;(6):98–104. (In Russ.) Available at: http://elib.fesmu.ru/elib/Article.aspx?id=253567.

25. Nadyrchenko R.M., Abdrakhimova N.A., Imelbayeva E.A., Hismatullina Z.R., Gareyev E.M. Rol of correction of level of interleukin-1β in therapy of numulyarny microbic eczema. Russian Journal of Immunology. 2016;10(19):322–323. (In Russ.) Available at: https://www.elibrary.ru/item.asp?id=32774987.

26. Havlickova B., Czaika V., Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses. 2008;51:2–15. https://doi.org/10.1111/j.1439-0507.2008.01606.x.

27. Haslund P., Bangsgaard N., Jarlov J.O., Skov R., Agner T. Staphylococcus aureus and hand eczema severity. Br J Dermatol. 2009;161(4):772–777. https://doi.org/10.1111/j.1365-2133.2009.09353.x.

28. Jayasekera A., Jennings L., Holden C.R., Bates C., Gawkrodger J. Methicillinresistant Staphylococcus aureus in skin disease affects mainly elderly pa-tients with eczema and leg ulcers who have associated chronic disease. Acta Derm Venereol. 2008;88(2):156–158. https://doi.org/10.2340/00015555-0351.

29. Silina L.V., Schwartz N.E. A skin microbiome at microbic eczema. Klinicheskaya Dermatologiya i Venerologiya. 2019;18(1):49–55. (In Russ.) https://doi.org/10.17116/klinderma20191801149.

30. Kasikhina E.I., Glazko I.I., Riabchikova M.D. Problems related to mixed infections: solutions and features of pathogenesis. Klinicheskaya Dermatologiya i Venerologiya. 2014;12(4):56–60. (In Russ.) Available at: https://www.mediasphera.ru/issues/klinicheskaya-dermatologiya-i-venerologiya/2014/4/031997-28492014410.

31. Sokolova T.V., Grigoryan S.A., Mokronosova M.A. The specific features of the course of candidiasis-complicated microbial eczema and its management. Russian Journal of Skin and Venereal Diseases. 2007;(1):13–20. (In Russ.) Available at: https://www.elibrary.ru/item.asp?id=9512511.

32. Sohn A., Frankel A., Patel R.V., Goldenberg G. Eczema. Mt Sinai J Med. 2011;78(5):730–739. https://doi.org/10.1002/msj.20289.

33. Shams K., Grindlay D.J., Williams H.C. What’s new in atopic eczema? An analysis of systematic reviews published in 2009–2010. Clin Exp Dermatol. 2011;36(6):573–577. https://doi.org/10.1111/j.1365-2230.2011.04078.x.


Review

For citations:


Kovaleva JS, Komkina NG. Microbic eczema – trigger points of influence. Meditsinskiy sovet = Medical Council. 2023;(2):37-44. (In Russ.) https://doi.org/10.21518/ms2022-031

Views: 558


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2079-701X (Print)
ISSN 2658-5790 (Online)